| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |